… This study demonstrates that the strategy of using a standardised regimen provides
acceptable results, but it also highlights the practical difficulties in establishing MDR-TB treatment …

… for the introduction of the Bangladesh or ‘shorter regimen’ to treat MDR-TB, the principles of
… their implementation under programmatic conditions in high MDR-TB prevalence settings. …

… the Bangladesh regimen, ie standardised shorter regimens. Our primary objective was to
estimate the probability of treatment success in MDR-TB patients treated with these regimens. …

… of longer duration, composed following WHO guidelines for the treatment of RR/MDR-TB.
Regimen definitions We defined shorter regimens as standardised regimens with an intended …

… Medicines for TB are also available in the private market in Bangladesh and the unregulated
private sector is likely to treat patients with TB using non-standardised regimen, which may …

… studies conducted in Bangladesh identified a nine-month regimen with very … regimen
studied in Bangladesh In recent years a number of meta-analyses of the outcomes of MDR-TB …

… The rationale used for the ‘Bangladesh’ regimen was also applied to our study:4 GFX was
used as the central drug due to evidence that the last-generation FQs have a bactericidal …

… doses of the constituent anti-TB drugs, FDCs are expected to … the use of FDCs in TB
programmes. The fundamental issue … Global TB Drug Facility (GDF) supplies quality TB drugs, …

… systems of the shortened standardised regimen as proposed in the Bangladesh study (study
regimen) compared to the locally used WHO-approved MDR-TB (control regimen). The …

… Except for the first regimen, which closely followed WHO recommendations, ethical clearance
was obtained for every regimen change from the Bangladesh Medical Research Council. …